Details for New Drug Application (NDA): 202506
✉ Email this page to a colleague
The generic ingredient in SILDENAFIL CITRATE is sildenafil citrate. There are twenty drug master file entries for this compound. Sixty-eight suppliers are listed for this compound. Additional details are available on the sildenafil citrate profile page.
Summary for 202506
Tradename: | SILDENAFIL CITRATE |
Applicant: | Watson Labs Inc |
Ingredient: | sildenafil citrate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 202506
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 25MG BASE | ||||
Approval Date: | Nov 25, 2020 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 50MG BASE | ||||
Approval Date: | Nov 25, 2020 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 100MG BASE | ||||
Approval Date: | Nov 25, 2020 | TE: | RLD: | No |
Complete Access Available with Subscription